Estrogen and folliculogenesis: Is one necessary for the other?

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 3, 2005, Pages 249-253

  Kolibianakis, Efstratios M ^a   Papanikolaou, Evangelos G ^a   Fatemi, Human M ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

aERKO; ArKO; bERKO; Estradiol; Folliculogenesis; Knockout mice; Ovulation

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

FERTILIZATION IN VITRO; GONADOTROPIN RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KNOCKOUT MOUSE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; OVULATION; PRIORITY JOURNAL; REVIEW;

EID: 18944402601     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000169101.83342.96     Document Type: Review

References (43)

1. Erickson GF, Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil Steril 2001; 76:943-949.
2. Olivennes F, Alvarez S, Bouchard P, et al. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 1998; 13:2411-2414.
3. Albano C, Felberbaum RE, Smitz J, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000; 15:526-531.
4. Felberbaum RE, Albano C, Ludwig M, et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000; 15:1015-1020.
5. Richards JS. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 1980; 60:51-89.
6. Hernandez ER, Roberts CT Jr, LeRoith D, Adashi EY. Rat ovarian insulin-like growth factor I (IGF-I) gene expression is granulosa cell-selective: 5′-untranslated mRNA variant representation and hormonal regulation. Endocrinology 1989; 125:572-574.
7. Richards JS. Estradiol receptor content in rat granulosa cells during follicular development: modification by estradiol and gonadotropins. Endocrinology 1975; 97:1174-1184.
8. Burghardt RC, Anderson E. Hormonal modulation of gap junctions in rat ovarian follicles. Cell Tissue Res 1981; 214:181-193.
9. Wang XN, Greenwald GS. Synergistic effects of steroids with FSH on folliculogenesis, steroidogenesis and FSH- and hCG-receptors in hypophysectomized mice. J Reprod Fertil 1993; 99:403-413.
10. Kaipia A, Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol 1997; 59:349-363.
11. Leung PC, Armstrong DT. Estrogen treatment of immature rats inhibits ovarian androgen production in vitro. Endocrinology 1979; 104:1411-1417.
12. Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998; 95:15677-15682.
13. Drummond AE, Baillie AJ, Findlay JK. Ovarian estrogen receptor alpha and beta mRNA expression: impact of development and estrogen. Mol Cell Endocrinol 1999; 149:153-161.
14. Sar M, Welsch F. Differential expression of estrogen receptor-beta and estrogen receptor-alpha in the rat ovary. Endocrinology 1999; 140:963-971.
15. Sharma SC, Clemens JW, Pisarska MD, Richards JS. Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology 1999; 140:4320-4334.
16. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001; 81:1535-1565.
17. Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001; 63:165-192.
18. Meyers MJ, Sun J, Carlson KE, et al. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001; 44:4230-4251.
19. Harris HA, Albert LM, Leathurby Y, et al. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003; 144:4241-4249.
20. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology 2002; 143:4172-4177.
21. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993; 90:11162-11166.
22. Couse JF, Hewitt SC, Bunch DO, et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999; 286:2328-2331.
23. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 1998; 95:6965-6970.
24. Schomberg DW, Couse JF, Mukherjee A, et al. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 1999; 140:2733-2744.
25. Couse JF, Curtis SW, Washburn TF, et al. Disruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings. Biochem Soc Trans 1995; 23:929-935.
26. Rosenfeld CS, Murray AA, Simmer G, et al. Gonadotropin induction of ovulation and corpus luteum formation in young estrogen receptor-alpha knockout mice. Biol Reprod 2000; 62:599-605.
27. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999; 20:358-417.
28. Couse JF, Bunch DO, Lindzey J, et al. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology 1999; 140:5855-5865.
29. Dupont S, Krust A, Gansmuller A, et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127:4277-4291.
30. Hawkins MB, Thornton JW, Crews D, et al. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci U S A 2000; 97:10751-10756.
31. Britt KL, Drummond AE, Cox VA, et al. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 2000; 141:2614-2623.
32. Couse JF, Yates MM, Sanford R, et al. Formation of cystic ovarian follicles associated with elevated luteinizing hormone requires estrogen receptor-beta. Endocrinology 2004; 145:4693-4702. In this study it was shown that ERb is necessary for full manifestation of the luteinizing hormone (LH) hypersecretion. For that purpose, female mice were generated that possess elevated LH, but lack ERb by breeding LHbCTP and ERb-null (bERKO) mice.
33. Risma KA, Clay CM, Nett TM, et al. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 1995; 92:1322-1326.
34. Hegele-Hartung C, Siebel P, Peters O, et al. Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci USA 2004; 101:5129-5134. In this study the effects of isotype-selective estrogen receptor agonists on ovarian and uterine biology as well as ovarian gene expression were investigated. It was shown that estrogen mediated ovulation inhibition and stimulation of uterine growth are mediated by ERa but not by ERb. ERb exerts direct estrogen effects on ovarian follicular development.
35. Starup J, Sele V. Premature ovarian failure. Acta Obstet Gynecol Scand 1973; 52:259-268.
36. Check JH, Check ML, Katsoff D. Three pregnancies despite elevated serum FSH and advanced age: case report. Hum Reprod 2000; 15:1709-1712.
37. Huynh K, Jones G, Thouas G, et al. Estrogen is not directly required for oocyte developmental competence. Biol Reprod 2004; 70:1263-1269. The question asked in this study was whether the young ArKO ovary is capable of responding to a protocol of superovulation induction and whether the observed oocytes are capable of sustaining fertilization and subsequent development. It was shown that estrogen is indirectly required for ovulation as a negative regulator of gonadotropin production, but is not essential to maintain reproductive fitness of immature mammalian oocytes.
38. Britt KL, Saunders PK, McPherson SJ, et al. Estrogen actions on follicle formation and early follicle development. Biol Reprod 2004; 71:1712-1723. The purpose of this study was to define the role for E2 in primordial follicle formation and activation by assessing the numbers of primordial and primary follicles. It was shown that E2 has a role in controlling the size of the oocyte and primordial follicle pool in mice.
39. Rajkovic A, Pangas SA, Ballow D, et al. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 2004; 305:1157-1159. In this study it was shown that lack of Nobox, an oocyte-specific homeobox gene, accelerates postnatal oocyte loss and abolishes the transition from primordial to growing follicles in mice.
40. Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997; 67:889-899.
41. Kolibianakis EM, Albano C, Camus M, et al. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab 2003; 88:5632-5637.
42. School DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994; 9:1237-1242.
43. Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod 2004; 19:2446-2453. This is a systematic review on the association of E2 on the day of human chorionic gonadotropin (hCG) administration and achievement of pregnancy in IVF. It was shown that there is no high-quality evidence to support or deny the value of E2 determination on the day of hCG administration for pregnancy achievement in IVF cycles, when pituitary downregulation is performed with GnRH agonists. Existing retrospective studies suggest that there is no positive association.